Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study

Abstract Background Systemic Lupus Erythematosus (SLE) affects all organ systems. As a result, fat intake and sedentary life are evident in the modern world. The prevalence of metabolic syndrome, with its components, increased, leading to increased mortality. We aimed to investigate the prevalence o...

Full description

Saved in:
Bibliographic Details
Main Authors: Noura Mallouhi, Ahmad Nabil Alhouri, Naram Khalayli, Hasan Nabil Alhouri, Mayssoun Kudsi, Younes Kabalan
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s41927-024-00453-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559025239457792
author Noura Mallouhi
Ahmad Nabil Alhouri
Naram Khalayli
Hasan Nabil Alhouri
Mayssoun Kudsi
Younes Kabalan
author_facet Noura Mallouhi
Ahmad Nabil Alhouri
Naram Khalayli
Hasan Nabil Alhouri
Mayssoun Kudsi
Younes Kabalan
author_sort Noura Mallouhi
collection DOAJ
description Abstract Background Systemic Lupus Erythematosus (SLE) affects all organ systems. As a result, fat intake and sedentary life are evident in the modern world. The prevalence of metabolic syndrome, with its components, increased, leading to increased mortality. We aimed to investigate the prevalence of metabolic syndrome in SLE and its relationship with disease activity. Methods A cross-sectional study was conducted on 70 SLE patients at Al Mouwasat University Hospitals in Damascus, Syria, between November 2021 and November 2022. The patients were divided into two groups based on the presence or absence of metabolic syndrome. The SLE Disease Activity Index (SLEDAI) was assessed in each group and compared with different disease parameters. Results Out of the 70 patients, 65 were females. The mean age was 32.19 ± 7.15 years, and the mean disease duration was 4.4 ± 2.96 years. Metabolic syndrome was found in 32 patients (45.7%). Metabolic syndrome in SLE patients was associated with a higher disease activity index, older age, delayed age at first diagnosis, longer disease duration, higher frequency of renal involvement, and use of cyclophosphamide. Conclusion Our study highlights the importance of evaluating and treating metabolic syndrome and its components in patients with SLE, as it may play a role in controlling disease activity. We recommend conducting larger studies in the future to overcome the limitations of this research, such as including a larger number of patients, conducting multicenter studies to generalize the results, and including a healthy control group.
format Article
id doaj-art-b44de12aa252411f97968c48784d9385
institution Kabale University
issn 2520-1026
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Rheumatology
spelling doaj-art-b44de12aa252411f97968c48784d93852025-01-05T12:49:40ZengBMCBMC Rheumatology2520-10262025-01-01911710.1186/s41927-024-00453-zAssessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional studyNoura Mallouhi0Ahmad Nabil Alhouri1Naram Khalayli2Hasan Nabil Alhouri3Mayssoun Kudsi4Younes Kabalan5Rheumatology Department, Damascus UniversityDiagnostic Radiology Department, Damascus UniversityPsychiatry Department, Damascus UniversityInternal Medicine Department, Damascus UniversityRheumatology Department, Damascus UniversityEndocrinology Department, Damascus UniversityAbstract Background Systemic Lupus Erythematosus (SLE) affects all organ systems. As a result, fat intake and sedentary life are evident in the modern world. The prevalence of metabolic syndrome, with its components, increased, leading to increased mortality. We aimed to investigate the prevalence of metabolic syndrome in SLE and its relationship with disease activity. Methods A cross-sectional study was conducted on 70 SLE patients at Al Mouwasat University Hospitals in Damascus, Syria, between November 2021 and November 2022. The patients were divided into two groups based on the presence or absence of metabolic syndrome. The SLE Disease Activity Index (SLEDAI) was assessed in each group and compared with different disease parameters. Results Out of the 70 patients, 65 were females. The mean age was 32.19 ± 7.15 years, and the mean disease duration was 4.4 ± 2.96 years. Metabolic syndrome was found in 32 patients (45.7%). Metabolic syndrome in SLE patients was associated with a higher disease activity index, older age, delayed age at first diagnosis, longer disease duration, higher frequency of renal involvement, and use of cyclophosphamide. Conclusion Our study highlights the importance of evaluating and treating metabolic syndrome and its components in patients with SLE, as it may play a role in controlling disease activity. We recommend conducting larger studies in the future to overcome the limitations of this research, such as including a larger number of patients, conducting multicenter studies to generalize the results, and including a healthy control group.https://doi.org/10.1186/s41927-024-00453-zSystemic lupus erythematosusMetabolic syndromePrevalenceSyria
spellingShingle Noura Mallouhi
Ahmad Nabil Alhouri
Naram Khalayli
Hasan Nabil Alhouri
Mayssoun Kudsi
Younes Kabalan
Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
BMC Rheumatology
Systemic lupus erythematosus
Metabolic syndrome
Prevalence
Syria
title Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
title_full Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
title_fullStr Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
title_full_unstemmed Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
title_short Assessing the relation between systemic lupus erythematosus and metabolic syndrome in Syria: a cross-sectional study
title_sort assessing the relation between systemic lupus erythematosus and metabolic syndrome in syria a cross sectional study
topic Systemic lupus erythematosus
Metabolic syndrome
Prevalence
Syria
url https://doi.org/10.1186/s41927-024-00453-z
work_keys_str_mv AT nouramallouhi assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy
AT ahmadnabilalhouri assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy
AT naramkhalayli assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy
AT hasannabilalhouri assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy
AT mayssounkudsi assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy
AT youneskabalan assessingtherelationbetweensystemiclupuserythematosusandmetabolicsyndromeinsyriaacrosssectionalstudy